The binding of a herpes simplex virus type 1 (HSV-1) encoded polypeptide to a viral origin of DNA replication has been studied by using a gel retardation assay. Incubation of nuclear extract from HSV-1 infected cells with a labelled origin-containing fragment resulted in the formation of a specific retarded complex, the migration of which was further reduced in the presence of an antibody reactive with the UL9 gene product. Introduction of an additional copy of the UL9 gene, under the control of an immediate early (IE) promoter, conferred the ability to express origin binding activity at the non-permissive temperature upon an HSV-1 _ts_ mutant blocked at the IE stage of infection. Endogenous or exogenous proteolytic activity revealed the presence of a relatively protease-resistant domain which retained sequence-specific DNA binding activity. The C-terminal 317 amino acids of the UL9 gene expressed as a fusion protein in Escherichia coli also bound to the origin.
INTRODUCTION
The herpes simplex virus type 1 (HSV-1) genome is a linear double-stranded DNA of approximately 152 kb. Replication of this genome requires the presence of cis-acting elements which function as origins of DNA replication and of virus-encoded trans-acting proteins which perform essential roles in DNA synthesis.
The complete sequence of the HSV-1 genome has been determined and open reading frames capable of encoding 70 distinct polypeptides identified (1) . Two approaches have indicated that the products of seven of these genes (UL5, UL8, 0L9, UL29, OL30, UL42 and UL52) are involved in viral DNA ©IRLPress 1*09
replication. Firstly, genetic analyses of HSV-1 mutants have shown that seven complementation groups containing mutants which exhibit defects in DNA synthesis map to these genes (2) (3) (4) (5) (6) (7) (8) (9) (10) . Secondly, Challberg and his colleagues have demonstrated, using a plasmid amplification assay for HSV-1 origin-dependent DNA replication, that the products of these seven genes are both necessary and sufficient for DNA synthesis (11) (12) (13) . Three of these seven DNA replication genes encode previously wellcharacterized proteins; the major single-strand-specific DNA binding protein is encoded by UL29 (3, 14) , the viral DNA polymerase by UL30 (14, 15) , and a 65,000 molecular weight protein which binds sequence-independently to double stranded DNA by UL42 (16, 17) . The products of the other four genes (0L5, UL8, UL9 and OL52) have not been so well characterized and are presumed to be present in much lower abundance in infected cells.
The viral origins of DNA replication are specified by two distinct but related sequences. One (ori ) lies close to the centre of the long unique <U L ) region whilst the other (ori g ) is present within the inverted repeats, TR and IR C (18-21 and Figure la) . DNA fragments of 100 bp or less which specify a functional orig have been identified (22) (23) (24) and include a 45 bp near perfect palindrome with a central A+T-rich region. Although the sequence specifying ori L contains a much longer (144 bp) palindrome there is high sequence similarity between the two origins covering the region of the ori palindrome and approximately 40 bp to one side of it.
Using a DNase I footprinting assay Elias and his colleagues (25, 26) have demonstrated the presence of two specific binding sites for a virus-induced polypeptide within . Site I consists of an 18 bp region which overlaps the left end of the ori_ palindrome (Figure lb) . Lower affinity binding occurs to site II which is present in the opposite orientation to site I and is identical in 15 of the corresponding 18 positions. Two copies of a sequence which differs in only one position from that of site I are similarly located within ori. and are also assumed to act as binding sites. Elias and Lehman (26) showed that the origin-binding protein (OBP) had a molecular weight of 83,000, but the viral gene encoding it was not identified. It seemed very likely however that OBP would be the product of one of the four genes essential for HSV-1 DNA synthesis to which a function had not yet been ascribed. We therefore developed a gel retardation assay to facilitate the testing of the UL5, UL8, UL9 and UL52 gene products for origin-binding activity. Our results confirm and extend the very recent report by Olivo et al. (27) that the UL9 gene specifies OBP.
MATERIALS AND METHODS
Cells and viruses; Baby hamster kidney 21 clone 13 (BHK) cells (28) were grown in Eagle's medium supplemented with 10% tryptose phosphate broth and 10% foetal calf serum. Extracts were prepared from cell monolayers (10 cells/90 mm plastic Petri dish) infected with 5-10 p.f.u./cell and incubated for 8 h at 37°C or 38.5°C. The viruses used were wild type (wt) HSV-1 (Glasgow strain 17, syn ), the HSV-1 temperature-sensitive mutant _ts_K (29) and recombinant viruses _tsK/OL5, tsK/UL8, ttsK/ULi9 and ^s_K/UL52. The recombinant viruses contain additional copies of the early genes Oi.5, UL8, UL9 and UL52 inserted under the control of the immediate early (IE) gene 3 promoter within the thymidine kinase gene of t^K. They were constructed essentially as described by Hummel et al. (30) . Preparation of nuclear extracts: In initial experiments nuclear extracts were prepared by the method of Piette et al. (31) from 3 infected cell monolayers. Proteins eluted from nuclei with buffer B containing 600 mM NaCl were precipitated with (NH.J-SO. and resuspended in 100 pi buffer B containing 100 mM NaCl. Subsequently it was noted that a procedure essentially as described by Dignam et al. (32) and modified by Preston et al. (33) gave greater reproducibility in terms of yield and activity. The nuclear pellet from 3 cell monolayers was eluted with 100 pi buffer C (20 mM Hepes pH 7.9, 25% glycerol, 1.5 mM MgCl., 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTT) containing 600 mM NaCl and after centrifugation the supernatant extract was flash frozen and stored at -70°C. Protein concentrations were determined by using a Bic-Rad Protein Assay kit.
Expression in Escherichia coli; Fusion proteins containing parts of the UL9 polypeptide were synthesised using the plasmid vector system pRlT2T (supplied by Pharmacia; ref. 34) . Two additional plasmids were constructed such that the Smal, BamHI, Sail and patl cloning sites ( Figure 6a) were positioned in the 2 other reading frames. EcoRl cleaved pRlT2T DNA was treated with mung bean nuclease to remove precisely the single-stranded overhangs and the plasmid recircularised either in the absence or presence of an 8 bp EcoRI linker (GGAATTCC). Resulting plasmids pRIT2T-4 and pRIT2T+4 respectively contain deletions and insertions of 4 bp and their identities were confirmed by DNA sequencing. DNA fragments were inserted into the appropriate plasmid as described in Figure 6 and the constructs used to transform E. coli strain K12AHlAtrp (35) to ampicillin resistance. Bacteria containing the desired plasmids were isolated and propagated at 28°C. To induce synthesis of the fusion protein bacteria were grown to an A630 value of 0.4 in 50 ml L broth and rapidly shifted to 42°C for 75 min. The cells were harvested by centrifugation, washed twice with lOmM Tris-HCl pH 7.5, lmM EDTA and resuspended in 0.5 ml buffer C containing 600 mM KCl. The suspension was extensively sonicated and centrifuged at 11,600 g for 10 min. The resulting supernatant was used as extract in the binding assays. DNA fragments and oligonucleotides; The 100 bp BamHI/Sall orig-containing fragment from plasmid pS19 (22) was recloned between the corresponding sites of pTZ19U (36) and used as a source of the HSV-1 ori sequence (pS19 fragment). Plasmid pBY3 contains an unrelated but similarly sized Haelll fragment of HSV-1 DNA originating from within BamHI y_ (37) and cloned into the Smal site of pTZ19U. Oligonucleotides were synthesised using a model 8600 Biosearch DNA synthesiser and purified on a 15% acrylamide DNA sequencing gel. Duplex oligonucleotides were formed by mixing equivalent masses of the two complementary strands, heating to 9 5°C and allowing to cool slowly to room temperature. The duplex oligonucleotides were end-labelled and blunt-ended using the filling-in reactions of the Klenow fragment of DNA polymerase I (38) . The following duplex oligonucleotides were used: non-denaturing acrylamide gels, extracted sequentially with phenol and chloroform and precipitated with ethanol. Either 1 ng labelled oligonucleotide or 5 ng of labelled 100 bp ori_ fragment were incubated at 25 C with 2 pg sonicated calf thyraus DNA and 5 pg extract in a 20 pi reaction mix containing 1 x buffer C plus 100 mM NaCl. After 20 rain 5 pi loading buffer (25% glycerol, 0.05% bromophenol blue in 1 x TBE [90 mM Tris-borate, 2.5 mM EDTA]) were added and the samples loaded onto 5% polyacrylamide gels (55:1, acrylamide:N,N'-methylene bisacrylamide) containing 1 x TBE. Gels were run in 1 x TBE at 25 mA for 1.5-2 h, fixed in 10% acetic acid, dried and exposed for autoradiography. Antisera: Rabbit antisera raised against decapeptides from the C-termini of the UL5, UL8, UL9 and UL52 gene products and reactive with the corresponding polypeptides (27) were kindly provided by Dr M.D. Challberg. 1 pi of antiserum was added to binding reactions.
RESULTS
Detection of ori.-. binding activity in nuclear extracts of cells infected with wt HSV-1. The sequence of part of the 100 bp HSv-1 DNA insert of plasraid pS19, which specifies functional ori activity (22) , is shown in Figure lb together with the two binding sites for a viral polypeptide mapped by Elias and Lehman (26) . Double-stranded oligonucleotides containing the sequences of binding sites I and II (oligonucleotide I and oligonucleotide II respectively) were synthesised and used with the 100 bp pS19 fragment in a gel retardation assay for the presence of proteins binding to these sites.
In initial experiments proteins eluted with 600 mM NaCl from nuclei of mock-infected and HSV-1 infected cells were precipitated with (NH.J-SO. and redissolved in buffer B plus 100 mM NaCl (31) . These extracts were incubated with end-labelled pS19 fragments in the presence of sonicated calf thymus DNA and sequence specific competitor DNAs. The reaction products were analysed by electrophoresis through 5% non-denaturing polyacrylamide gels. Figure 2 shows the results of a typical experiment. In the absence of added competitor DNA two retarded bands (A and B) representing protein-DNA complexes were detected (track 1). To verify the specificity of binding, 100-fold molar excesses of unlabelled ori fragment (track 2), oligonucleotides I and II (tracks 3 and 4) and the 100 bp insert of plasmid pBY3 (containing unrelated HSV-1 DNA sequences [track 5]) were added to the assay. The ori-fragment and oligonucleotides I and II competed efficiently for binding resulting in a great decrease in the signal intensity of bands A and B. In contrast the pBY3 fragment did not compete. Complexes A and B therefore result from site specific binding to DNA sequences present within oligonucleotides I and II, and probably represent the same activity as previously detected by DNase footprinting (26) . No
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A-PFiqure 2. Gel retardation analysis of extracts of at HSV-1 infected cells. Nuclear extract was incubated with 32 P endlabelled pS19 fragment either in the absence of competitor DNA (track 1) or in the presence of 100-fold molar excesses of unlabelled pS19 fragment (track 2), oligonucleotide I (track 3), oligonucleotide II (track 4) or pBY3 fragment (track 5). The products were separated by electrophoresis in a 5% nondenaturing polyacrylamide gel. A and B indicate specific retarded complexes and P the free probe. similar activity was detected in extracts from mock-infected cells (e.g. Figure 3a , track 1).
The product of the UL9 gene interacts with binding site I. The recombinant viruses t£K/UL5, tsK/Ui.8, tsK/UL9 and tsK/OL52 contain additional copies of the early genes 0L5, UL8, UL9 and UL52 inserted into the genome of the HSV-1 temperature-sensitive mutant _tsK under the control of the immediate early (IE) gene 3 promoter. At the non-permissive temperature (38.5°C) tsK accumulates IE polypeptides but fails to induce the expression of early and late genes (29, 40) . The 4 recombinant viruses exhibit polypeptide profiles at 38.5°C indistinguishable from tsK with the exception that each induces a single additional polypeptide corresponding to the product of the inserted gene (J.M. Calder and N.D. Stow, manuscript in preparation).
Proteins were eluted with 600 mM NaCl from the nuclei of mock-infected cells and from cells infected at the non-permissive temperature with wt HSV-1, ^£K or the four recombinant viruses. The extracts were tested in a gel retardation assay using P-labelled oligonucleotide I as probe ( Figure 3a) . As expected, extract from cells infected with wt HSV-1 generated a major complex (A) and some minor bands (track 2). The only other extract which caused significant retardation of the probe fragment was from cells infected with recombinant virus t^K/UL9 (track 6). Although the pattern of retardation observed with extracts from cells infected with this virus varied from assay to assay the presence of material which failed to enter the gel and of a smear extending down most of the track were consistently observed. In addition, whereas somewhat diffuse bands migrating more slowly than complex A were usually seen, bands co-migrating with complex A were absent. . Effect of antisera on the wt HSV-1 complex. Nuclear extract From cells infected with wt HSV-1 was incubated with P-labelled oligonucleotide I either in the absence of added antiserum (track 1) or in the presence of antisera reactive with the UL5, 0L8, 0L9 or UL52 gene products (tracks 2, 3, 4 and 5 respectively). The products were analysed as described in Figure 2 . A and A' indicate the major complexes formed in the absence of antiserum or in the presence of antiserum against the 0L9 gene product respectively. oligonucleotide X (which is a similar size but of unrelated DNA sequence) efficiently competed for binding.
Because the ^s_K/UL9 recombinant differs from tj3K only in its ability to express the UL9 gene product at the non-permissive temperature the data indicate that this polypeptide participates in the formation of a complex with binding site I.
The UL9 gene product is present in complex A formed with extracts from cells infected with wt HSV-1. Nuclear extract from cells infected with wt HSV-1 was incubated with Plabelled oligonucleotide I either in the absence of added antibody or in the presence of antibodies reactive with the UL5, UL8, UL9 or UL52 polypeptides and the products analysed on a non-denaturing polyacrylamide gel. Figure 4 shows that the antibodies which react with UL5, 0L8 or 0L52 had little effect m, A- Figure 5 . Effect of proteinase K on the _ts_K/UIi9 complex. Nuclear extract-from cells infected with recombinant tsK/UL9 was incubated with P-labelled oligonucleotide I either in the absence of proteinase K (track 1) or in the presence of 1, 10, 100, 1000 or 2000 ng proteinase K (tracks 1-6 respectively). Wt HSV-1 extract was assayed in parallel in the absence of proteinase (track 7). The products were analysed as described in Figure 2 . "A" indicates the major complex formed with wt extract.
on the pattern of retarded fragments. In contrast addition of antibody to the 0L9 polypeptide resulted in the loss of the major retarded complex, A, and its replacement by a more slowly migrating form. A', indicative of the additional presence of antibody molecules in the complexes. Therefore at least a part of the UL9 polypeptide is contained within complex A, and since the antibody was raised against a C-terminal oligopeptide (27) this region of the protein must be present.
Effect of protease digestion on the binding activity from cells infected with the tsK/UL9 recombinant. Given that the major retarded complex from cells infected with wt HSV-1 reacted with an antibody against the UL9 polypeptide it was rather surprising that the pattern of retarded fragments observed using extract from cells infected with the ^sK/UL9 recombinant was very different. One possible explanation is that complex A contains only a fragment of the UL9 polypeptide.
Our attempts to size complex A using pore-gradient polyacrylamide gels (41) had suggested a molecular weight of approximately 45,000, clearly inconsistent with the binding of an intact UL9 polypeptide (molecular weight 94,000) to the labelled oligonucleotide (data not shown). We therefore examined the effect of proteinase K addition to binding reactions containing _ts_K/(JL9 nuclear extract and labelled oligonucleotide I. The results ( Figure 5) show that with increasing amount of added proteinase K there is a reduction in the amount of slowly migrating complexes and a concomitant appearance of a faster migrating species which exhibits a mobility very similar to that of complex A. No band of this mobility was detected when extracts from mock-infected cells or The data thus suggest that the addition of proteinase K to extracts containing the UL9 polypeptide results in the cleavage of the polypeptide and the generation of a relatively protease-resistant domain which retains DNA binding activity. Expression of the DNA binding domain of DL9 in Escherichia coli. Three DNA fragments representing approximately the N-terminal 2/3 and C-terminal 2/3 and 1/3 of the UL9 coding sequences were cloned in the correct reading frame into the vector pRIT2T or an appropriate frameshift derivative (see Figure 6 and Materials and Methods). The constructs were introduced into E. coli strain K12AHlAtrp, extracts prepared from heat induced bacteria, and tested for binding activity using 32 P-labelled oligonucleotide I. No binding activity was detected in extracts from the host bacteria alone or following the introduction of the vector pRIT2T ( Figure 7 , tracks 2 and 4). Of the three hybrid plasmids pBl (track 3) and pP31 but not pX8 encoded binding activity. The activity encoded by pBl also binds to the 100 bp ori -containing fragment and is efficiently competed by the addition of unlabelled oligonucleotides I and II but not oligonucleotide X (tracks 5-8). The C-terminal 317 amino acids of the 09 polypeptide therefore contain all the amino acid sequences required for sequence-specific binding to sites I and II within ori . Figure 7 also shows that the fusion protein encoded by pBl (predicted molecular weight 63/000) forms a complex which exhibits a considerably lower mobility than complex A formed using extract from cells infected with wt HSV-1 (tracks 9 and 10), in agreement with complex A containing only a proteolytic fragment of the UL9 polypeptide. The mobility of the pBl complex was further reduced by the addition of antibodies reactive with the UL9 or UL52 polypeptides to the binding reaction (tracks [11] [12] [13] . The ability of both these antibodies to bind to the DNA protein complex results from the presence of the protein A moiety in the pBl fusion protein, and verifies that the hybrid protein is responsible for the observed binding.
DISCUSSION
The initial objective of the experiments presented in this paper was to identify the HSV-1 gene product which recognises the two specific binding sites within HSV-1 ori c characterised by Elias and Lehman (26) . The expression of binding activity in E. coli indicates that the only viral polypeptide essential for this activity is encoded by the UL9 gene and very strongly suggests that this gene product is directly responsible for sequence specific binding. Our identification of the UL9 polypeptide as an origin-binding protein is in complete agreement with the recent results of Olivo et al. (27) who expressed this viral protein in a baculovirus expression system and assayed for binding by an immunoprecipitation assay and ONase footprinting.
In addition to expressing binding activity in E. coli we also detected binding using nuclear extracts from cells infected with wt HSV-1 or the recombinant virus _tsK/UL9 . Competition experiments with synthetic oligonucleotidea demonstrated that in each instance the binding target contained sequences homologous to binding sites I and II initially characterised by Elias and Lehman (26) . The baculovirus-expressed UL9 polypeptide protected similar DNA sequences in DNase footprinting experiments (27) .
By employing a gel retardation assay we were able to distinguish different sizes of complex formed by the addition of extracts from various sources. These results are interesting to compare with other recent reports which examined origin-binding activity by the same technique. The rapidly migrating complex A detected with extracts from cells infected with wt HSV-1 clearly contains only a portion of the UL9 gene product. This complex appears to be similar to the major complex described recently by Koff and Tegtmeyer (42) . In contrast Elias and Lehman (26) purified origin binding activity from virus infected cells and observed a major (presumably intact) polypeptide of molecular weight 83,000 and two smaller components. This preparation gave a very different pattern, more closely resembling that obtained with _tsk/UL9 extracts, in a gel retardation assay. This suggests that in extracts of cells infected with wt HSV-1 the 0L9 polypeptide may be subjected to varying extents of proteolytic cleavage. We do not know whether the small forms observed by ourselves and by Koff and Tegtmeyer (42) are of any physiological significance or whether they merely reflect proteolytic activity occurring during the isolation procedure. The observation that extracts made in parallel from cells infected with the _tsk/0L9 recombinant do not contain the cleaved form of the polypeptide responsible for the formation of complex A suggests that the proteolytic activity occurs as a consequence of infection proceeding from the IE to early and late stages, and could thus possibly be virus encoded.
Although interaction of intact 0L9 polypeptide with labelled probe fragments produces a smeared pattern in a gel retardation assay this nevertheless represents sequence-specific binding (Figure 3 and ref. 26) . The smearing may occur because of aggregation and/or dissociation of complexes during incubation of the binding reactions and gel electrophoresis. This behaviour is not so noticeable in complexes containg only proteolytic fragments of UL9 or fragments synthesized in E. coli where much "tighter" bands are observed. The smearing may therefore be a consequence of interactions involving the N-terminal region of the UL9 polypeptide.
By expressing a fragment of the UL9 polypeptide in E. coli we have demonstrated that the C-terminal 317 amino acids specify all the structural information required for sequence-specific recognition and binding. A similar situation has previously been noted for another herpesvirus sequence-specific DNA binding protein, EBNA-1 of Epstein-Barr virus, the C-terminal domain of which is able to bind to its target recognition sequence (43) . In addition, discrete domains of several other proteins are known to be responsible for sequence-specific binding to DNA and these are often relatively resistant to the action of added protease (41, (44) (45) (46) (47) (48) .
It is likely that sequence-specific recognition of the HSV-1 origins of DNA replication is a very early event in initiation of HSV-1 DNA synthesis. Following binding of the UL9 polypeptide to the origins, regions of the protein not involved in direct interaction with DNA probably participate in other functions which may include interacting with other replication proteins, or unwinding or nicking DNA to facilitate the initiation of DNA synthesis. Expression systems for the UL9 polypeptide such as those described in this paper should prove useful in the study of these functions.
